{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:48:04Z","timestamp":1772848084651,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mbc.0b013e32835e98bf","type":"journal-article","created":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T11:57:26Z","timestamp":1370692646000},"page":"525-531","source":"Crossref","is-referenced-by-count":25,"title":["P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting"],"prefix":"10.1097","volume":"24","author":[{"given":"Naguib","family":"Zoheir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah Abd","family":"Elhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Abulata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehry El.","family":"Sobky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Khafagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4892(03)00007-9","article-title":"Platelet purinergic receptors.","volume":"3","author":"Kunapuli","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"R2-11-20210203","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.ATV.19.8.2007","article-title":"Specific impairment of human platelet P2Y (AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel.","volume":"19","author":"Geiger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/ATVBAHA.107.160689","article-title":"P2Y12 antagonism: promises and challenges.","volume":"28","author":"Michelson","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R4-11-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.12.001","article-title":"3rd, et al. ACCAHASCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (ACCAHASCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R5-11-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1160\/TH11-05-0306","article-title":"The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.","volume":"107","author":"Bouman","year":"2012","journal-title":"Thromb Haemost"},{"key":"R6-11-20210203","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.0000085073.69189.88","article-title":"Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.","volume":"108","author":"Fontana","year":"2003","journal-title":"Circulation"},{"key":"R7-11-20210203","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2010.11.023","article-title":"Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation.","volume":"127","author":"Lee","year":"2011","journal-title":"Thromb Res"},{"key":"R8-11-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.ATV.0000148708.44691.27","article-title":"Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.","volume":"25","author":"Hetherington","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-11-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events.","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-11-20210203","first-page":"247","article-title":"Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases.","volume":"45","author":"Sirotkina","year":"2009","journal-title":"Genetika"},{"key":"R11-11-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2350-8-59","article-title":"Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.","volume":"8","author":"Cavallari","year":"2007","journal-title":"BMC Med Genetics"},{"key":"R12-11-20210203","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.thromres.2005.03.001","article-title":"Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.","volume":"116","author":"Angiolillo","year":"2005","journal-title":"Thromb Res"},{"key":"R13-11-20210203","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.thromres.2007.01.012","article-title":"Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.","volume":"120","author":"Cuisset","year":"2007","journal-title":"Thromb Res"},{"key":"R14-11-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2006.02.006","article-title":"Genetic polymorphisms of the platelet receptors P2Y (12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.","volume":"119","author":"Lev","year":"2007","journal-title":"Thromb Res"},{"key":"R15-11-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.ATV.0000148708.44691.27","article-title":"Dimorphism in the P2Y1 ADP Receptor Gene is associated with increased platelet activation response to ADP.","volume":"25","author":"Hetherington","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-11-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.thromres.2005.11.009","article-title":"Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease.","volume":"118","author":"Schettert","year":"2006","journal-title":"Thromb Res"},{"key":"R17-11-20210203","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jacc.2011.06.044","article-title":"Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary PCI for STEMI. Results from the ARMYDA-6 MI (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty--Myocardial Infarction) randomized study.","volume":"58","author":"Patti","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R18-11-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial.","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"R19-11-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2010.04.008","article-title":"Rationale and design of the randomized, double-blind trial testing intravenous and Oral administration of elinogrel, a selective and reversible P2Y (12)-receptor inhibitor, versus clopidogrel to evaluate Tolerability and Efficacy in non urgent Percutaneous Coronary Interventions patients (INNOVATE-PCI).","volume":"160","author":"Leonardi","year":"2010","journal-title":"Am Heart J"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e32835e98bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:31:15Z","timestamp":1620959475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201307000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32835e98bf","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}